Skip to main content

Nutrient Deficiency

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Mutiply-fortified saltN/A1 trial
Active Trials
NCT05166980Completed1,389Est. May 2024
Shape Therapeutics
Shape TherapeuticsWA - Seattle
1 program
NutrigeneticN/A1 trial
Active Trials
NCT05342766Completed46Est. Oct 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Colorado TherapeuticsMutiply-fortified salt
Shape TherapeuticsNutrigenetic

Clinical Trials (2)

Total enrollment: 1,435 patients across 2 trials

NCT05166980Colorado TherapeuticsMutiply-fortified salt

Study of Multiply-fortified Salt Among Women of Reproductive Age and Preschool Children in India

Start: Oct 2022Est. completion: May 20241,389 patients
N/ACompleted

Precision Nutrition

Start: May 2022Est. completion: Oct 202346 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.